Original articleNovel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity

Add time:08/23/2019    Source:sciencedirect.com

Novel 1-(2-aryl-2-adamantyl)piperazine derivatives have been synthesized and evaluated in vitro for their antitumor properties against HeLa cervical carcinoma, MDA MB 231 breast cancer, MIA PaCa2 pancreatic cancer, and NCI H1975 non-small cell lung cancer. The parent piperazine 6 was found to exhibit a reasonable activity toward the HeLa and MDA MB 231 tumor cell lines (IC50= 9.2 and 8.4 μΜ, respectively). Concurrent benzene ring C4-fluorination and piperidine acetylation of the piperazino NH of compound 6 resulted in the most active compound 13 of the series in both of the above cell lines (IC50=8.4 and 6.8 μΜ, respectively). Noticeably, compounds 6 and 13 exhibited a significantly low cytotoxicity level over the normal human cells HUVEC (Human Umbilical Vein Endothelial Cells) and NHDF (Normal Human Dermal Fibroblasts).

We also recommend Trading Suppliers and Manufacturers of 4-(1-adamantyl)-3,5-dimethyl-1H-pyrazole (cas 108221-12-1). Pls Click Website Link as below: cas 108221-12-1 suppliers

Prev:Synthesis of some fused pyridine-and oxazole-polycyclic systems from 10-(methoxyimino)phenanthren-9-one
Next:A short-cut from 1-acetyl adamantane to 2-(1-adamantyl)pyrroles)